These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10619467)

  • 41. Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist.
    Invernizzi R; Pozzi L; Samanin R
    Neuropharmacology; 1995 Feb; 34(2):211-5. PubMed ID: 7617146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amino acid levels and gamma-aminobutyric acidA receptors in rat neostriatum, cortex, and thalamus after neonatal 6-hydroxydopamine lesion.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurochem; 1993 Mar; 60(3):936-45. PubMed ID: 8382266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
    Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
    Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different effects of opiate withdrawal on dopamine turnover, uptake, and release in the striatum and nucleus accumbens.
    Ghosh S; Patel AH; Cousins M; Grasing K
    Neurochem Res; 1998 Jun; 23(6):875-85. PubMed ID: 9572677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treating neonatal rats with 6-hydroxydopamine induced an increase in voluntary alcohol consumption.
    Yoshimoto K; Kaneda S; Kawai Y; Ueda S; Takeuchi Y; Matsushita H; Yuri K; Yasuhara M
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):2S-6S. PubMed ID: 10235268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1997 Dec; 340(1):53-8. PubMed ID: 9527506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain.
    Toide K
    Pharm Res; 1990 Jun; 7(6):670-2. PubMed ID: 1973292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis.
    Nakahara D; Fuchikami K; Ozaki N; Iwasaki T; Nagatsu T
    Brain Res; 1992 Mar; 574(1-2):164-70. PubMed ID: 1638391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 6-Hydroxydopamine lesions of the medial prefrontal cortex of rats do not affect dopamine metabolism in the basal ganglia at short and long postsurgical intervals.
    Bubser M
    Neurochem Res; 1994 Apr; 19(4):421-5. PubMed ID: 8065499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat.
    Amalric M; Moukhles H; Nieoullon A; Daszuta A
    Eur J Neurosci; 1995 May; 7(5):972-80. PubMed ID: 7613632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
    Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell.
    King D; Zigmond MJ; Finlay JM
    Neuroscience; 1997 Mar; 77(1):141-53. PubMed ID: 9044382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis.
    Leslie CA; Robertson MW; Cutler AJ; Bennett JP
    Brain Res Dev Brain Res; 1991 Sep; 62(1):109-14. PubMed ID: 1836980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: effect of drugs, circadian changes and correlations with motor activity.
    O'Neill RD; Fillenz M
    Neuroscience; 1985 Sep; 16(1):49-55. PubMed ID: 3835502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.